We are live on
!
Find out more
Two Sigma Advisers Portfolio holdings
AUM
$51.4B
1-Year Est. Return
31.07%
This Fund
S&P 500
This Quarter
Est. Return
-3.02%
1 Year Est. Return
+31.07%
3 Year Est. Return
+128.94%
5 Year Est. Return
+161.75%
10 Year Est. Return
+607.04%
AUM
$34.5B
AUM Growth
-$708M
(-2%)
Cap. Flow
+$1.23B
Cap. Flow
% of AUM
3.55%
Top 10 Holdings %
Top 10 Hldgs %
13.77%
Holding
2,852
New
233
Increased
919
Reduced
1,343
Closed
332
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enphase Energy
ENPH
|
+$342M |
| 2 |
Intel
INTC
|
+$276M |
| 3 |
TSMC
TSM
|
+$237M |
| 4 |
Procter & Gamble
PG
|
+$178M |
| 5 |
JPMorgan Chase
JPM
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$383M |
| 2 |
Occidental Petroleum
OXY
|
+$321M |
| 3 |
PayPal
PYPL
|
+$316M |
| 4 |
S&P Global
SPGI
|
+$145M |
| 5 |
Datadog
DDOG
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.57% |
| 2 | Healthcare | 17.95% |
| 3 | Financials | 9.89% |
| 4 | Industrials | 9.61% |
| 5 | Consumer Discretionary | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Universal Electronics
UEIC
$59.2M
| $411K | ﹤0.01% |
20,900
+4,500
| +27% | +$106K |
|
|
UNIT
1927
Uniti Group
UNIT
$2.52B
| $410K | ﹤0.01% |
59,000
-99,600
| -63% | -$925K |
|
1928
Cue Biopharma
CUE
$118M
| $409K | ﹤0.01% |
6,110
-1,027
| -14% | -$88.3K |
|
1929
Nature's Sunshine
NATR
$362M
| $409K | ﹤0.01% |
49,600
-19,900
| -29% | -$198K |
|
1930
Nexa Resources
NEXA
$1.61B
| $409K | ﹤0.01% |
79,300
+23,400
| +42% | +$135K |
|
1931
First Citizens BancShares
FCNCA
$24.7B
| $408K | ﹤0.01% |
512
-1,300
| -72% | -$1.02M |
|
1932
Kanzhun
BZ
$7.19B
| $407K | ﹤0.01% |
24,100
+8,900
| +59% | +$201K |
|
1933
Fulcrum Therapeutics
FULC
$241M
| $407K | ﹤0.01% |
50,300
-61,000
| -55% | -$437K |
|
|
SCWX
1934
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $407K | ﹤0.01% |
50,598
-6,900
| -12% | -$68.4K |
|
|
IVC
1935
DELISTED
Invacare Corporation
IVC
| $406K | ﹤0.01% |
519,945
-130,911
| -20% | -$138K |
|
1936
Dianthus Therapeutics
DNTH
$5.69B
| $405K | ﹤0.01% |
17,963
-5,181
| -22% | -$142K |
|
1937
ICICI Bank
IBN
$107B
| $405K | ﹤0.01% |
+19,300
| New | +$408K |
|
|
OGI
1938
Organigram Holdings
OGI
$131M
| $404K | ﹤0.01% |
115,893
-38,775
| -25% | -$162K |
|
1939
Astrana Health
ASTH
$1.81B
| $402K | ﹤0.01% |
10,300
-18,200
| -64% | -$833K |
|
1940
BOK Financial
BOKF
$8.58B
| $400K | ﹤0.01% |
4,500
-2,400
| -35% | -$208K |
|
1941
Freshworks
FRSH
$3.21B
| $396K | ﹤0.01% |
30,500
-27,900
| -48% | -$395K |
|
1942
Mid Penn Bancorp
MPB
$974M
| $396K | ﹤0.01% |
13,800
-5,600
| -29% | -$161K |
|
|
PRO
1943
DELISTED
PROS Holdings
PRO
| $395K | ﹤0.01% |
+16,000
| New | +$388K |
|
1944
InfuSystem Holdings
INFU
$197M
| $394K | ﹤0.01% |
56,400
-7,100
| -11% | -$59.5K |
|
|
WW
1945
DELISTED
WW International
WW
| $394K | ﹤0.01% |
+100,200
| New | +$607K |
|
1946
Corvus Pharmaceuticals
CRVS
$1.1B
| $393K | ﹤0.01% |
480,100
+106,700
| +29% | +$102K |
|
|
GNTY
1947
DELISTED
Guaranty Bancshares
GNTY
| $393K | ﹤0.01% |
11,370
-6,300
| -36% | -$226K |
|
|
SPNS
1948
DELISTED
Sapiens International
SPNS
| $393K | ﹤0.01% |
20,500
+3,800
| +23% | +$86K |
|
|
CFLT
1949
DELISTED
Confluent
CFLT
| $392K | ﹤0.01% |
16,500
-34,700
| -68% | -$935K |
|
|
TGB
1950
Trekor Metals
TGB
$2.45B
| $391K | ﹤0.01% |
342,900
-486,000
| -59% | -$528K |
|
Similar funds
CWM
VRS
FAF
BGIM
CIM
PPFA
Two Sigma Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Two Sigma Advisers held 2,852 positions worth $34.5B, down 2% from $35.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Two Sigma Advisers deployed $1.23B of net new capital in Q3 2022, opening 233 new positions and adding to 919 existing holdings. Its largest new stake was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Netflix, an estimated $383M trimmed.
- Two Sigma Advisers's largest Q3 2022 buy was State Street SPDR S&P Biotech ETF: 1,329,800 shares worth $105M.
- Two Sigma Advisers added most to Enphase Energy in Q3 2022, an estimated $342M increase.
- Two Sigma Advisers's biggest Q3 2022 reduction was Netflix, cutting an estimated $383M.
- Two Sigma Advisers fully exited S&P Global in Q3 2022, selling an estimated $145M.
- Two Sigma Advisers's ten largest holdings make up 14% of its $34.5B portfolio in Q3 2022.
- Two Sigma Advisers opened 233 new positions and closed 332 in Q3 2022.
- Two Sigma Advisers's portfolio value fell 2% quarter-over-quarter to $34.5B.
Based on Two Sigma Advisers's 13F filing for Q3 2022, filed 14 Nov 2022.